Leumas is building pharma’s most agile production infrastructure—scaling both horizontally and vertically.

Horizontally, we’re expanding our proven Gen 3 platform—originally designed for small-molecule OSDs and topicals—into high-potency and specialty products with built-in containment for safe, unmanned HPAPI manufacturing.

Vertically, we’re attempting to build a modular, robotic platform for peptide drug substance manufacturing. This compact system enables continuous SPPS, purification, and formulation—fully automated and digitally orchestrated.

Together, these dual tracks position Leumas as one of the few platforms capable of powering the entire pharma value chain—from niche drug products to precision peptide APIs—with unmatched agility, cost-efficiency, and GMP-grade automation.